# Study of Blood Samples From Newborns With Down Syndrome

> **NCT00959283** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 180 (actual)

## Conditions studied

- Myeloid Proliferations Associated With Down Syndrome

## Interventions

- **OTHER:** Diagnostic Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study

## Key facts

- **NCT ID:** NCT00959283
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-23
- **Primary completion:** 2011-12-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2023-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959283, "Study of Blood Samples From Newborns With Down Syndrome". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00959283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*